Aminisani Nayyereh, Wood Timothy, Waite Ben, Seeds Ruth, Jelley Lauren, Wong Conroy, Sue Huang Q
Wallaceville Science Centre, Institute of Environmental Science and Research.
Department of Respiratory Medicine, Te Whatu Ora, Health NZ Counties Manukau, Auckland.
J Infect Dis. 2025 Jul 16;232(Supplement_1):S59-S68. doi: 10.1093/infdis/jiaf226.
BACKGROUND: Unlike influenza, information on the risk of human metapneumovirus (HMPV) infections in adults with chronic medical conditions (CMCs) is less robust. METHODS: The SHIVERS project (Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance) performed a population-based surveillance of acute respiratory illness hospitalizations in Auckland, New Zealand, from 2012 to 2015. In this analysis, we linked these surveillance data to population-based administrative data to estimate the age- and ethnicity-adjusted risk of HMPV-associated hospitalization during the study period among adults by certain CMCs: chronic obstructive pulmonary disease, asthma, congestive heart failure, coronary artery disease, cerebrovascular accidents, diabetes mellitus, and end-stage renal disease. RESULTS: Overall, HMPV hospitalization rates were significantly higher across all ages and ethnic groups among adults with CMCs than those without any condition. In imputed analysis, the CMC with the highest risk of HMPV hospitalization across age groups was congestive heart failure (incidence rate ratio [IRR] range, 7.0-23.0), followed by coronary artery disease (IRR range, 4.2-9.1) and chronic obstructive pulmonary disease (IRR range, 6.7-11.9) in adults aged ≥50 years. The CMC with the highest risk of HMPV hospitalization was congestive heart failure in Māori/Pacific adults and chronic obstructive pulmonary disease in non-Māori/Pacific adults. Adults with ≥2 CMCs had a higher risk than those without CMCs; the risk varied by age group and ethnicity. CONCLUSIONS: Adults with specific or ≥2 CMCs are at increased risk of HMPV hospitalizations. Age and ethnicity affect this relationship for some CMCs but not all. Such populations may benefit from future HMPV prevention strategies.
背景:与流感不同,关于患有慢性疾病(CMC)的成年人感染人偏肺病毒(HMPV)风险的信息尚不充分。 方法:“寒颤”项目(南半球流感与疫苗效力研究及监测)于2012年至2015年在新西兰奥克兰开展了一项基于人群的急性呼吸道疾病住院监测。在本分析中,我们将这些监测数据与基于人群的行政数据相链接,以估算在研究期间特定慢性疾病(慢性阻塞性肺疾病、哮喘、充血性心力衰竭、冠状动脉疾病、脑血管意外、糖尿病和终末期肾病)患者中,按年龄和种族调整后的HMPV相关住院风险。 结果:总体而言,患有慢性疾病的成年人在所有年龄组和种族中的HMPV住院率均显著高于无任何疾病的成年人。在推算分析中,各年龄组中HMPV住院风险最高的慢性疾病是充血性心力衰竭(发病率比[IRR]范围为7.0 - 23.0),其次是≥50岁成年人中的冠状动脉疾病(IRR范围为4.2 - 9.1)和慢性阻塞性肺疾病(IRR范围为6.7 - 11.9)。在毛利/太平洋岛民成年人中,HMPV住院风险最高的慢性疾病是充血性心力衰竭;在非毛利/太平洋岛民成年人中则是慢性阻塞性肺疾病。患有≥2种慢性疾病的成年人比无慢性疾病的成年人风险更高;风险因年龄组和种族而异。 结论:患有特定慢性疾病或≥2种慢性疾病的成年人HMPV住院风险增加。年龄和种族对某些慢性疾病存在这种关联,但并非对所有慢性疾病都如此。这类人群可能会从未来的HMPV预防策略中受益。
Influenza Other Respir Viruses. 2025-7
Ther Adv Respir Dis. 2021
J Infect Dis. 2020-1-2
Clin Epidemiol. 2017-3-15
Influenza Other Respir Viruses. 2015-7